应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CRVO CervoMed
休市中 04-10 16:00:00 EDT
3.83
-0.20
-4.96%
盘后
3.83
+0.00
0.00%
19:55 EDT
最高
4.12
最低
3.82
成交量
3.54万
今开
4.03
昨收
4.03
日振幅
7.44%
总市值
3,544万
流通市值
1,890万
总股本
925.27万
成交额
13.98万
换手率
0.72%
流通股本
493.43万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
CervoMed将于2026年路易体痴呆协会年会公布Neflamapimod临床项目进展并参与生物标志物专题讨论
美股速递 · 04-07
CervoMed将于2026年路易体痴呆协会年会公布Neflamapimod临床项目进展并参与生物标志物专题讨论
CervoMed于2026年Ad/Pd™科学会议公布新数据,进一步证实Neflamapimod对无阿尔茨海默病共病理的路易体痴呆患者具有积极疗效
美股速递 · 03-19
CervoMed于2026年Ad/Pd™科学会议公布新数据,进一步证实Neflamapimod对无阿尔茨海默病共病理的路易体痴呆患者具有积极疗效
CervoMed确定针对路易体痴呆症患者的三期临床试验配方及给药方案
美股速递 · 03-04
CervoMed确定针对路易体痴呆症患者的三期临床试验配方及给药方案
Cervomed Inc.盘中异动 股价大涨5.14%
市场透视 · 03-04
Cervomed Inc.盘中异动 股价大涨5.14%
CervoMed旗下Neflamapimod获选纳入英国Experts-ALS平台,旨在优先推进肌萎缩侧索硬化症的潜力疗法
美股速递 · 02-18
CervoMed旗下Neflamapimod获选纳入英国Experts-ALS平台,旨在优先推进肌萎缩侧索硬化症的潜力疗法
Cervomed Inc.盘中异动 下午盘股价大跌5.17%报7.15美元
市场透视 · 01-15
Cervomed Inc.盘中异动 下午盘股价大跌5.17%报7.15美元
CervoMed将在第18届阿尔茨海默病临床试验会议上分享Neflamapimod治疗路易体痴呆的新数据
美股速递 · 2025-11-24
CervoMed将在第18届阿尔茨海默病临床试验会议上分享Neflamapimod治疗路易体痴呆的新数据
Cervomed Inc.盘中异动 急速下跌6.68%报7.66美元
市场透视 · 2025-11-18
Cervomed Inc.盘中异动 急速下跌6.68%报7.66美元
Cervomed Inc.盘中异动 早盘股价大跌5.21%报6.91美元
市场透视 · 2025-11-08
Cervomed Inc.盘中异动 早盘股价大跌5.21%报6.91美元
Cervomed Inc.盘中异动 大幅上涨5.56%报7.41美元
市场透视 · 2025-11-04
Cervomed Inc.盘中异动 大幅上涨5.56%报7.41美元
CervoMed公布与FDA就Neflamapimod在路易体痴呆注册路径达成一致
美股速递 · 2025-11-04
CervoMed公布与FDA就Neflamapimod在路易体痴呆注册路径达成一致
Cervomed Inc.盘中异动 急速跳水5.19%
市场透视 · 2025-10-22
Cervomed Inc.盘中异动 急速跳水5.19%
Cervomed Inc.盘中异动 早盘快速下跌5.15%
市场透视 · 2025-02-18
Cervomed Inc.盘中异动 早盘快速下跌5.15%
Cervomed Inc.盘中异动 急速下跌5.02%报2.08美元
市场透视 · 2025-02-11
Cervomed Inc.盘中异动 急速下跌5.02%报2.08美元
Cervomed Inc.盘中异动 临近午盘股价大涨5.50%
市场透视 · 2025-01-24
Cervomed Inc.盘中异动 临近午盘股价大涨5.50%
Cervomed Inc.盘中异动 临近收盘快速上涨5.21%报2.22美元
市场透视 · 2025-01-22
Cervomed Inc.盘中异动 临近收盘快速上涨5.21%报2.22美元
Cervomed Inc.盘中异动 股价大跌5.16%
市场透视 · 2025-01-09
Cervomed Inc.盘中异动 股价大跌5.16%
Cervomed Inc.盘中异动 股价大跌5.03%报2.21美元
市场透视 · 2025-01-06
Cervomed Inc.盘中异动 股价大跌5.03%报2.21美元
Cervomed Inc.盘中异动 早盘大幅拉升5.83%报2.36美元
市场透视 · 2025-01-03
Cervomed Inc.盘中异动 早盘大幅拉升5.83%报2.36美元
Cervomed Inc.盘中异动 早盘快速跳水5.69%报2.25美元
市场透视 · 2024-12-31
Cervomed Inc.盘中异动 早盘快速跳水5.69%报2.25美元
加载更多
公司概况
公司名称:
CervoMed
所属市场:
NASDAQ
上市日期:
--
主营业务:
CervoMed Inc.最初于1995年1月10日根据内华达州法律注册成立,并于2015年6月18日在特拉华州重新注册成立。该公司是一家临床阶段的生物技术公司,专注于开发与年龄相关的神经系统疾病的治疗方法。他们的主要候选药物neflamapimod是一种在研的口服小分子药物,能够轻松穿过血脑屏障,并选择性地抑制p38α酶——一种神经炎症和突触功能障碍的关键驱动因素。通过靶向脑部退行性疾病的关键病理过程,neflamapimod有望逆转突触功能障碍,改善神经元健康,并延缓或阻止疾病进展。Neflamapimod目前正处于治疗路易体痴呆 (DLB)(其主要适应症)以及非流利型原发性进行性失语症 (nfvPPA)、类风湿性关节炎 (RAS) 和肌萎缩侧索硬化症 (ALS) 的临床开发阶段。
发行价格:
--
{"stockData":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":3.83,"timestamp":1775851200000,"preClose":4.03,"halted":0,"volume":35387,"hourTrading":{"tag":"盘后","latestPrice":3.83,"preClose":3.83,"latestTime":"19:55 EDT","volume":97,"amount":376.45,"timestamp":1775865333371,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04962779156327547,"floatShares":4934300,"shares":9252719,"eps":-2.982424,"marketStatus":"休市中","change":-0.2,"latestTime":"04-10 16:00:00 EDT","open":4.03,"high":4.12,"low":3.82,"amount":139814.5076471,"amplitude":0.074442,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.982424,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776067200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.03,"postHourTrading":{"tag":"盘后","latestPrice":3.83,"preClose":3.83,"latestTime":"19:55 EDT","volume":97,"amount":376.45,"timestamp":1775865333371,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8201066756226004},"requestUrl":"/m/hq/s/CRVO","defaultTab":"news","newsList":[{"id":"1163917918","title":"CervoMed将于2026年路易体痴呆协会年会公布Neflamapimod临床项目进展并参与生物标志物专题讨论","url":"https://stock-news.laohu8.com/highlight/detail?id=1163917918","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163917918?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:31","pubTimestamp":1775561473,"startTime":"0","endTime":"0","summary":"CervoMed宣布,公司计划在2026年路易体痴呆协会年度会议上,详细介绍其核心候选药物Neflamapimod的临床研发项目最新数据与进展。此外,CervoMed的研究专家还将受邀参与一场关于生物标志物的专题小组讨论,分享在该领域的见解与发现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190106082","title":"CervoMed于2026年Ad/Pd™科学会议公布新数据,进一步证实Neflamapimod对无阿尔茨海默病共病理的路易体痴呆患者具有积极疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1190106082","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190106082?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:33","pubTimestamp":1773920016,"startTime":"0","endTime":"0","summary":"CervoMed在2026年Ad/Pd™科学会议上公布了最新研究数据,这些数据强化了Neflamapimod药物对不伴有阿尔茨海默病共病理的路易体痴呆患者的治疗效果。新发现突显该疗法在特定患者群体中的显著优势,为精准医疗提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186895438","title":"CervoMed确定针对路易体痴呆症患者的三期临床试验配方及给药方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1186895438","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186895438?lang=zh_cn&edition=full","pubTime":"2026-03-04 20:32","pubTimestamp":1772627574,"startTime":"0","endTime":"0","summary":"CervoMed已正式确定其针对路易体痴呆症患者的三期临床试验的最终配方及给药方案。这一关键决策标志着该公司在推进神经退行性疾病治疗研究方面迈出了重要一步,为后续临床试验的开展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616287587","title":"Cervomed Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616287587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616287587?lang=zh_cn&edition=full","pubTime":"2026-03-04 03:07","pubTimestamp":1772564827,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日03时07分,Cervomed Inc.股票出现异动,股价快速上涨5.14%。截至发稿,该股报4.09美元/股,成交量5.2395万股,换手率0.57%,振幅7.67%。Cervomed Inc.股票所在的生物技术行业中,整体跌幅为1.90%。其相关个股中,Edesa Biotech, Inc.、Onconetix, Inc.、Calcimedica, Inc.涨幅较大,Edesa Biotech, Inc.、Adial Pharmaceuticals, Inc、Onconetix, Inc.较为活跃,换手率分别为296.56%、138.89%、128.97%,振幅较大的相关个股有Edesa Biotech, Inc.、Onconetix, Inc.、Yd Bio Ltd C/Wts 28/08/2030,振幅分别为76.32%、47.36%、43.99%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304030708a69ea6fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304030708a69ea6fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173716197","title":"CervoMed旗下Neflamapimod获选纳入英国Experts-ALS平台,旨在优先推进肌萎缩侧索硬化症的潜力疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1173716197","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173716197?lang=zh_cn&edition=full","pubTime":"2026-02-18 19:02","pubTimestamp":1771412559,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布,其研发的候选药物Neflamapimod已被遴选加入英国Experts-ALS平台。该平台的核心目标在于识别并优先推进针对肌萎缩侧索硬化症(ALS)最具前景的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603621395","title":"Cervomed Inc.盘中异动 下午盘股价大跌5.17%报7.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603621395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603621395?lang=zh_cn&edition=full","pubTime":"2026-01-15 04:08","pubTimestamp":1768421338,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日04时08分,Cervomed Inc.股票出现波动,股价大幅下跌5.17%。截至发稿,该股报7.15美元/股,成交量4.623万股,换手率0.50%,振幅3.51%。Cervomed Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115040859a4c46e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115040859a4c46e38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126237005","title":"CervoMed将在第18届阿尔茨海默病临床试验会议上分享Neflamapimod治疗路易体痴呆的新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1126237005","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126237005?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:02","pubTimestamp":1763985767,"startTime":"0","endTime":"0","summary":"CervoMed将在第18届阿尔茨海默病临床试验会议上分享Neflamapimod治疗路易体痴呆的新数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584917508","title":"Cervomed Inc.盘中异动 急速下跌6.68%报7.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584917508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584917508?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:31","pubTimestamp":1763476294,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时31分,Cervomed Inc.股票出现异动,股价大幅跳水6.68%。截至发稿,该股报7.66美元/股,成交量6829股,换手率0.07%,振幅2.07%。Cervomed Inc.股票所在的生物技术行业中,整体跌幅为0.43%。其相关个股中,Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Clearmind Medicine Inc.涨幅较大,Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃,换手率分别为941.48%、452.82%、265.25%,振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd,振幅分别为27.23%、16.40%、14.20%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223135950c6452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223135950c6452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581783100","title":"Cervomed Inc.盘中异动 早盘股价大跌5.21%报6.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581783100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581783100?lang=zh_cn&edition=full","pubTime":"2025-11-08 00:16","pubTimestamp":1762532193,"startTime":"0","endTime":"0","summary":"北京时间2025年11月08日00时16分,Cervomed Inc.股票出现波动,股价快速下跌5.21%。截至发稿,该股报6.91美元/股,成交量1.6724万股,换手率0.18%,振幅4.73%。Cervomed Inc.股票所在的生物技术行业中,整体跌幅为0.86%。其相关个股中,Surrozen Inc C/Wts 01/08/2031 、Puma Biotechnology Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Metavia Inc.、Tharimmune, Inc.、Phio Pharmaceuticals Corp.较为活跃,换手率分别为157.35%、71.84%、28.33%,振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Tharimmune, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ,振幅分别为70.00%、37.11%、33.73%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108001634a6e92dbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108001634a6e92dbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581740156","title":"Cervomed Inc.盘中异动 大幅上涨5.56%报7.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581740156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581740156?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:56","pubTimestamp":1762268171,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日22时56分,Cervomed Inc.股票出现异动,股价大幅上涨5.56%。截至发稿,该股报7.41美元/股,成交量2.6815万股,换手率0.29%,振幅4.20%。Cervomed Inc.股票所在的生物技术行业中,整体跌幅为0.44%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Terns Pharmaceuticals, Inc.、Metsera, Inc.涨幅较大,Artelo Biosciences, Inc.、Abpro Holdings, Inc、Biomx Inc.较为活跃,换手率分别为278.07%、97.30%、67.72%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Terns Pharmaceuticals, Inc.、Nuvation Bio Inc.,振幅分别为36.13%、23.09%、22.63%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511042256119753ab53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511042256119753ab53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166172288","title":"CervoMed公布与FDA就Neflamapimod在路易体痴呆注册路径达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1166172288","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166172288?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:03","pubTimestamp":1762257793,"startTime":"0","endTime":"0","summary":"CervoMed公布与FDA就Neflamapimod在路易体痴呆注册路径达成一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577383770","title":"Cervomed Inc.盘中异动 急速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577383770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577383770?lang=zh_cn&edition=full","pubTime":"2025-10-22 01:22","pubTimestamp":1761067337,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日01时22分,Cervomed Inc.股票出现异动,股价大幅下挫5.19%。截至发稿,该股报7.12美元/股,成交量5.0418万股,换手率0.54%,振幅4.32%。Cervomed Inc.股票所在的生物技术行业中,整体跌幅为0.53%。其相关个股中,Minerva Neurosciences, Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Ibio, Inc.涨幅较大,Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃,换手率分别为2139.14%、273.87%、197.89%,振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Surrozen Inc C/Wts 01/08/2031 ,振幅分别为215.34%、100.00%、67.96%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022012217a46cc1ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022012217a46cc1ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512169419","title":"Cervomed Inc.盘中异动 早盘快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169419?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:05","pubTimestamp":1739891114,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时05分,Cervomed Inc.股票出现异动,股价大幅下跌5.15%。截至发稿,该股报2.21美元/股,成交量2.9744万股,换手率0.36%,振幅5.58%。Cervomed Inc.股票所在的生物技术行业中,整体涨幅为0.65%。其相关个股中,Solid Biosciences Inc.、Allogene Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为333.39%、127.78%、119.54%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.,振幅分别为41.79%、34.04%、33.58%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230514a24ab453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230514a24ab453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510360043","title":"Cervomed Inc.盘中异动 急速下跌5.02%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510360043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510360043?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:45","pubTimestamp":1739288742,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时45分,Cervomed Inc.股票出现异动,股价急速下挫5.02%。截至发稿,该股报2.08美元/股,成交量2.9468万股,换手率0.36%,振幅4.80%。Cervomed Inc.股票所在的生物技术行业中,整体跌幅为1.85%。其相关个股中,Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2719.51%、1098.32%、377.13%,振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.,振幅分别为58.60%、57.43%、40.87%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234542a2420bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234542a2420bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505045519","title":"Cervomed Inc.盘中异动 临近午盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505045519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505045519?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:40","pubTimestamp":1737650405,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时40分,Cervomed Inc.股票出现波动,股价大幅拉升5.50%。截至发稿,该股报2.30美元/股,成交量3.3895万股,换手率0.41%,振幅6.88%。Cervomed Inc.股票所在的生物技术行业中,整体涨幅为0.47%。其相关个股中,Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Exicure, Inc.涨幅较大,Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为3599.77%、2463.29%、660.66%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.,振幅分别为246.43%、64.29%、55.57%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240040059870d354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240040059870d354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505392781","title":"Cervomed Inc.盘中异动 临近收盘快速上涨5.21%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505392781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505392781?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:33","pubTimestamp":1737491581,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时33分,Cervomed Inc.股票出现波动,股价大幅上涨5.21%。截至发稿,该股报2.22美元/股,成交量6.6461万股,换手率0.81%,振幅5.92%。Cervomed Inc.股票所在的生物技术行业中,整体涨幅为1.85%。其相关个股中,Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大,Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃,换手率分别为1615.85%、528.30%、191.03%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 ,振幅分别为103.72%、96.32%、67.67%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122043301960bf5dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122043301960bf5dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502145703","title":"Cervomed Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502145703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502145703?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:28","pubTimestamp":1736357332,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日01时28分,Cervomed Inc.股票出现异动,股价快速跳水5.16%。截至发稿,该股报2.19美元/股,成交量8.3998万股,换手率1.02%,振幅4.56%。Cervomed Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大,Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为3430.46%、595.63%、588.02%,振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为192.73%、143.11%、89.00%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012852985f965a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012852985f965a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501901259","title":"Cervomed Inc.盘中异动 股价大跌5.03%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501901259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501901259?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:34","pubTimestamp":1736177699,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时34分,Cervomed Inc.股票出现波动,股价快速下跌5.03%。截至发稿,该股报2.21美元/股,成交量8.0961万股,换手率0.98%,振幅3.83%。Cervomed Inc.股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大,Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为1166.43%、306.55%、99.39%,振幅较大的相关个股有Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ,振幅分别为176.15%、71.31%、54.46%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106233459985cf371&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106233459985cf371&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500114209","title":"Cervomed Inc.盘中异动 早盘大幅拉升5.83%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500114209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500114209?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:41","pubTimestamp":1735915295,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时41分,Cervomed Inc.股票出现波动,股价急速拉升5.83%。截至发稿,该股报2.36美元/股,成交量7720股,换手率0.09%,振幅4.48%。Cervomed Inc.股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.涨幅较大,Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为971.62%、752.32%、268.94%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.,振幅分别为121.56%、75.47%、48.07%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103224135985a3f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103224135985a3f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495717615","title":"Cervomed Inc.盘中异动 早盘快速跳水5.69%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495717615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495717615?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:30","pubTimestamp":1735655452,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时30分,Cervomed Inc.股票出现异动,股价快速下跌5.69%。截至发稿,该股报2.25美元/股,成交量3935股,换手率0.05%,振幅0.00%。Cervomed Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,知临集团、Onconetix, Inc.、Eyenovia, Inc.涨幅较大,Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃,换手率分别为849.65%、617.36%、130.44%,振幅较大的相关个股有Eyenovia, Inc.、Onconetix, Inc.、Portage Biotech Inc.,振幅分别为18.27%、11.44%、10.12%。Cervomed Inc.公司简介:CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123122305295f42d11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123122305295f42d11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cervomed.com","stockEarnings":[{"period":"1week","weight":-0.0749},{"period":"1month","weight":-0.1335},{"period":"3month","weight":-0.5048},{"period":"6month","weight":-0.5301},{"period":"1year","weight":-0.5478},{"period":"ytd","weight":-0.5152}],"compareEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.0405},{"period":"1year","weight":0.2952},{"period":"ytd","weight":-0.0036}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CervoMed Inc.最初于1995年1月10日根据内华达州法律注册成立,并于2015年6月18日在特拉华州重新注册成立。该公司是一家临床阶段的生物技术公司,专注于开发与年龄相关的神经系统疾病的治疗方法。他们的主要候选药物neflamapimod是一种在研的口服小分子药物,能够轻松穿过血脑屏障,并选择性地抑制p38α酶——一种神经炎症和突触功能障碍的关键驱动因素。通过靶向脑部退行性疾病的关键病理过程,neflamapimod有望逆转突触功能障碍,改善神经元健康,并延缓或阻止疾病进展。Neflamapimod目前正处于治疗路易体痴呆 (DLB)(其主要适应症)以及非流利型原发性进行性失语症 (nfvPPA)、类风湿性关节炎 (RAS) 和肌萎缩侧索硬化症 (ALS) 的临床开发阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.023389},{"month":2,"riseRate":0.5,"avgChangeRate":0.085839},{"month":3,"riseRate":0.5,"avgChangeRate":0.326048},{"month":4,"riseRate":0.3,"avgChangeRate":-0.060435},{"month":5,"riseRate":0.444444,"avgChangeRate":0.146641},{"month":6,"riseRate":0.111111,"avgChangeRate":-0.121539},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.07795},{"month":8,"riseRate":0.666667,"avgChangeRate":0.076308},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.117703},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.039339},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.045938},{"month":12,"riseRate":0.3,"avgChangeRate":-0.206034}],"exchange":"NASDAQ","name":"CervoMed","nameEN":"CervoMed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CervoMed(CRVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CervoMed,CRVO,CervoMed股票,CervoMed股票老虎,CervoMed股票老虎国际,CervoMed行情,CervoMed股票行情,CervoMed股价,CervoMed股市,CervoMed股票价格,CervoMed股票交易,CervoMed股票购买,CervoMed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CervoMed(CRVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}